A Biomarker-related Approach to Screening for HPV-related Oropharyngeal Cancer
This is a questionnaire and oral mucosal sample study. The data obtained from this study will help develop new screening tests for oropharyngeal cancers. We hope to identify markers that can be detected in an oral gargle sample to screen for oropharyngeal cancer in the future.
Men will be recruited from the Head and Neck Cancer Program clinic at the Moffitt Cancer Center.
1. Recruit and enroll a cohort of 150 OPC cases prior to treatment from the Moffitt Head and Neck Cancer Program
a. Implement a short risk factor questionnaire
b. Collect an oral gargle and sponge specimen
c. Obtain the biopsy/tumor block for HPV and biomarker assessment
2. Estimate prevalence of the following markers from the oral gargle and sponge specimen and tumor block:
a. HPV genotype (DNA)
b. immunological factors (SLPI, oral cytokine profile)
c. HPV viral factors (e.g., HPV L1 methylation, variants, and integration status)
d. p16 expression (marker of HPV-mediated cell deregulation)
3. Assess concordance between markers detected in tumor and oral gargle specimens among OPC cases
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub